chr1-169854309-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020423.7(SCYL3):āc.1968G>Cā(p.Met656Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000041 in 1,608,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020423.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCYL3 | ENST00000367771.11 | c.1968G>C | p.Met656Ile | missense_variant | 12/13 | 1 | NM_020423.7 | ENSP00000356745.5 | ||
SCYL3 | ENST00000367770.5 | c.2130G>C | p.Met710Ile | missense_variant | 12/13 | 1 | ENSP00000356744.1 | |||
SCYL3 | ENST00000367772.8 | c.2130G>C | p.Met710Ile | missense_variant | 13/14 | 2 | ENSP00000356746.4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000215 AC: 53AN: 245996Hom.: 0 AF XY: 0.000203 AC XY: 27AN XY: 133260
GnomAD4 exome AF: 0.0000426 AC: 62AN: 1456788Hom.: 0 Cov.: 30 AF XY: 0.0000442 AC XY: 32AN XY: 724546
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.2130G>C (p.M710I) alteration is located in exon 13 (coding exon 12) of the SCYL3 gene. This alteration results from a G to C substitution at nucleotide position 2130, causing the methionine (M) at amino acid position 710 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at